Level C· Early human research exploring benefitsProspective StudyPubMed

[Effects of adipose-derived stem cells and endothelial cells on survival and neovascularization of fat tissue transplants].

Zhang J., Xiong B., Qiu J., Tan Q., Zhang Y., Yang J.

Prospective Study with a reported sample of 20, published in Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi (2018) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi (2018)
Country
China
Reported sample size
20
Source database
PubMed
PMID
30238738
PMCID
PMC8429997
DOI
10.7507/1002-1892.201802069
Citations
1

Abstract (original English)

To investigate the effects of adipose-derived stem cells (ADSCs) and endothelial cells (ECs) on the survival and neovascularization of fat tissue transplants. The ADSCs were isolated by collagenase digestion from the adipose tissues voluntarily donated by the patients undergoing mastectomy, and subcultured. The passage 3 ADSCs were used for subsequent experiments. The residual fat tissues were used to prepare fat particles (FPs). The human umbilical vein endothelial cells (HUVECs) were used as ECs for subsequent experiments. Eighty healthy male nude mice, aged 4-6 weeks, were randomly divided into 4 groups ( n =20). The mice were received subcutaneous injection at the dorsum of 1 mL FPs+0.3 mL normal saline (NS) in control group, 1 mL FPs+2×10 6 ECs+0.3 mL NS in ECs group, 1 mL FPs+2×10 6 ADSCs+0.3 mL NS in ADSCs group, and 1 mL FPs+1×10 6 ECs+1×10 6 ADSCs+0.3 NS in ADSCs+ECs group. General observations of the injection sites were performed, and the survival of the mice was recorded. At 2, 4, 8, and 12 weeks after injection, grafted fat tissues were firstly assessed by ultrasonography, then they were collected for volume measurement (water displacement method) and histology observation (HE staining and immunofluorescence staining). All mice survived until the end of experiment. At each time point, no significant difference was noted between groups in ultrasonography assay. Ther

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
Adipose TissueAnimalsBreast NeoplasmsCell DifferentiationEndothelial CellsHumansMaleMastectomyMiceMice, Nude

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.